Recombinant Protochlamydia amoebophila D-tyrosyl-tRNA (Tyr) deacylase (dtd)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify any format requirements in your order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested and pre-arranged. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50% and may serve as a useful reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
dtd; pc0356D-aminoacyl-tRNA deacylase; DTD; EC 3.1.1.96; Gly-tRNA(Ala) deacylase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-151
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Protochlamydia amoebophila (strain UWE25)
Target Names
dtd
Target Protein Sequence
MKLVIQRVLQ AQVYIDDNLF SAIGPGLMLL LGIHHQDNLE QILWSVDKLV HLRIFNDENG KMNRNVKECE GEILVVSQFT LYGNCLNGRR PDFIQAASPP IALSLYRQFI DELKKEAPHV KTGQFGAQMQ VSLTNDGPVT FILESLDRRK A
Uniprot No.

Target Background

Function
This aminoacyl-tRNA editing enzyme deacylates mischarged D-aminoacyl-tRNAs. It also deacylates mischarged glycyl-tRNA(Ala), protecting cells from glycine mischarging by AlaRS. The enzyme functions through tRNA-based, rather than protein-based, catalysis; rejecting L-amino acids instead of detecting D-amino acids at the active site. By recycling D-aminoacyl-tRNA into D-amino acids and free tRNA molecules, this enzyme mitigates the toxicity of D-aminoacyl-tRNA formation in vivo and contributes to maintaining protein L-homochirality.
Database Links

KEGG: pcu:pc0356

STRING: 264201.pc0356

Protein Families
DTD family
Subcellular Location
Cytoplasm.

Q&A

How does Protochlamydia amoebophila DTD compare to other bacterial DTDs?

Protochlamydia amoebophila DTD belongs to a family of enzymes found across all three domains of life. While the specific characteristics of P. amoebophila DTD are not extensively detailed in the provided search results, DTDs generally share highly conserved sequences and structural features across species. The active site motif in most DTD proteins is "SQFT," although variations exist, such as the "PQAT" motif found in human DTD2 .

P. amoebophila, as an endosymbiont of free-living amoebae, likely exhibits some unique adaptations in its DTD enzyme compared to those of other bacteria, reflecting its specialized intracellular lifestyle. These adaptations may involve modifications in substrate specificity or regulatory mechanisms that accommodate the metabolic environment of its amoeba host.

What metabolic features of Protochlamydia amoebophila influence DTD function?

Protochlamydia amoebophila elementary bodies (EBs), once thought to be metabolically inert, actually maintain significant metabolic activity even in their extracellular stage. Research has demonstrated that P. amoebophila EBs can uptake and metabolize D-glucose through the pentose phosphate pathway and exhibit host-independent activity of the tricarboxylic acid (TCA) cycle . This metabolic activity is essential for maintaining infectivity.

The sustained metabolic capability of P. amoebophila EBs suggests that DTD may remain active during this stage, continuing to prevent the incorporation of D-amino acids into proteins even outside the host cell. This would be particularly important for maintaining the integrity of proteins synthesized during the transitional phase between extracellular and intracellular existence, ensuring the chlamydial organism retains functional proteins necessary for successful infection and establishment within a new host cell.

What are the conserved structural motifs in DTD proteins?

DTD proteins contain several highly conserved structural motifs that are crucial for their function:

  • Active Site Motif: The "SQFT" motif is present in most DTD proteins, though some variants like human DTD2 contain a "PQAT" motif instead . This region is critical for the enzyme's catalytic activity.

  • Nucleophilic Threonine: The threonine residue within the active site motif acts as the main nucleophile in the hydrolysis reaction, attacking the carbonyl group of the D-amino acid linked to tRNA .

  • Enantioselectivity Motif: The "Gly-Cys-Pro" dipeptide sequence has been identified as responsible for maintaining homochirality by specifically selecting D-amino acids while rejecting L-amino acids .

  • Stabilization Residues: Phenylalanine and glutamine residues play important roles in stabilizing the oxyanion hole during the hydrolysis reaction .

These conserved motifs work together to ensure the enzyme's specificity for D-amino acid-charged tRNAs while avoiding the hydrolysis of correctly charged L-amino acid-tRNAs.

What methodological approaches are recommended for expressing recombinant Protochlamydia amoebophila DTD?

Expressing recombinant P. amoebophila DTD requires several specialized approaches due to the organism's intracellular lifestyle and unique characteristics:

Host System Selection:

  • Escherichia coli BL21(DE3) is commonly used for recombinant protein expression of chlamydial proteins .

  • For optimal expression, codon optimization of the P. amoebophila dtd gene may be necessary to accommodate the codon usage bias of the expression host.

Expression Vector Considerations:

  • Vectors containing T7 promoters are typically effective for controlled expression.

  • Inclusion of affinity tags (His-tag, GST) facilitates purification while minimizing interference with enzymatic activity.

Culture Conditions:

  • Induction with IPTG at lower temperatures (16-20°C) often improves the solubility of recombinant chlamydial proteins.

  • Extended expression times (16-24 hours) at these reduced temperatures can increase yield of properly folded protein.

Purification Protocol:

  • Harvest cells and lyse using sonication or pressure-based methods

  • Clarify lysate by centrifugation (20,000 × g for 30 minutes)

  • Perform initial capture using affinity chromatography

  • Further purify using size exclusion chromatography

  • Verify purity using SDS-PAGE and enzymatic activity assays

For studying structure-function relationships, researchers should consider expressing specific variants through site-directed mutagenesis of the conserved "SQFT" motif or the "Gly-Cys-Pro" dipeptide sequence responsible for enantioselectivity.

How can researchers assess the enzymatic activity of recombinant P. amoebophila DTD?

Assessment of DTD enzymatic activity requires specialized assays that measure the hydrolysis of D-amino acid-charged tRNAs:

Preparation of D-Tyr-tRNA^Tyr Substrate:

  • Enzymatically charge tRNA^Tyr with D-tyrosine using purified tyrosyl-tRNA synthetase

  • Verify charging efficiency using acid gel electrophoresis

  • Quantify the amount of charged tRNA using radioactive amino acids or other labeling methods

Activity Assay Methods:

  • Thin-Layer Chromatography (TLC) Method:

    • Incubate recombinant DTD with radiolabeled D-Tyr-tRNA^Tyr

    • Stop reaction at various time points

    • Separate free D-tyrosine from charged tRNA using TLC

    • Quantify the released D-tyrosine using phosphorimaging

  • Spectrophotometric Method:

    • Couple the deacylation reaction with auxiliary enzymes that produce a chromogenic or fluorogenic product

    • Monitor the increase in absorbance or fluorescence over time

    • Calculate initial velocities for kinetic analysis

  • Mass Spectrometry Method:

    • Incubate DTD with D-Tyr-tRNA^Tyr

    • Analyze reaction products using UPLC-MS

    • Quantify the released D-tyrosine and intact tRNA

Kinetic Parameter Determination:

  • Vary substrate concentration to determine Km and Vmax values

  • Compare activity with different D-amino acid-tRNA substrates

  • Assess the effect of pH, temperature, and ionic strength on activity

A typical assay would measure the deacylation rate at physiologically relevant conditions (pH 7.4, 37°C), with substrate concentrations ranging from 0.1-10× Km to accurately determine kinetic parameters.

What structural features contribute to the D-amino acid specificity of DTD?

The remarkable ability of DTD to discriminate between D- and L-amino acids stems from several key structural features:

Enantioselectivity Mechanism:
The "Gly-Cys-Pro" dipeptide plays a critical role in maintaining homochirality by specifically selecting D-amino acids while rejecting L-amino acids . This motif creates a chiral environment that accommodates the specific stereochemistry of D-amino acids.

Active Site Architecture:

  • The active site contains a threonine residue that functions as the main nucleophile, attacking the carbonyl group of the D-amino acid-tRNA ester bond .

  • Phenylalanine and glutamine residues help stabilize the oxyanion hole during the hydrolysis reaction .

Substrate Processing Pathway:
High-resolution enzyme-substrate structures have revealed three distinct subsites in the DTD enzyme:

  • Transition site: Where the D-amino acid-tRNA complex initially binds

  • Active site: Where the hydrolysis reaction occurs

  • Exit site: Where the products are released after hydrolysis

Mutational studies involving the replacement of the active site threonine with alanine have demonstrated the essential role of threonine in DTD's catalytic activity . The specific spatial arrangement of these features creates a selective environment that recognizes and processes only D-amino acid-tRNA complexes while excluding L-amino acid-tRNAs.

How does the metabolic activity of P. amoebophila elementary bodies influence DTD function?

P. amoebophila elementary bodies (EBs) maintain significant metabolic activity even in their extracellular stage, which has important implications for DTD function:

Metabolic Capabilities of P. amoebophila EBs:

  • Maintain respiratory activity

  • Uptake and metabolize D-glucose

  • Synthesize labeled metabolites from 13C-labeled D-glucose

  • Release labeled CO2, indicating active metabolism

  • Utilize the pentose phosphate pathway as the major route for D-glucose catabolism

  • Exhibit host-independent activity of the tricarboxylic acid (TCA) cycle

Implications for DTD Function:

  • Sustained Protein Synthesis: The metabolic activity in EBs suggests ongoing protein synthesis, which necessitates functional DTD to maintain translational fidelity.

  • Energy Requirements: Active DTD function requires ATP, which would be supplied by the metabolic pathways active in EBs.

  • Infectivity Maintenance: The essential role of D-glucose in sustaining metabolic activity in EBs directly impacts infectivity . This suggests that processes dependent on this metabolism, including potentially DTD activity, are crucial for maintaining infectious potential.

  • Stress Response: In nutrient-deprived conditions, the decline in infectivity suggests reduced metabolic activity, which may affect DTD function and allow misincorporation of D-amino acids into proteins.

This metabolic activity challenges the traditional view of chlamydial EBs as metabolically inert and suggests that DTD remains actively involved in quality control of protein synthesis even during the extracellular stage of the chlamydial developmental cycle.

What experimental challenges are associated with studying P. amoebophila DTD?

Researchers face several significant challenges when studying P. amoebophila DTD:

Cultivation Challenges:

  • P. amoebophila must be grown within amoeba hosts such as Acanthamoeba castellanii

  • Unsynchronized cultures result in mixed developmental stages

  • Purification of elementary bodies requires multiple freeze-thaw cycles and mechanical disruption

Expression Challenges:

  • Codon usage differences between P. amoebophila and standard expression hosts

  • Potential toxicity of overexpressed DTD to host cells

  • Proper folding may require specific chaperones not present in common expression systems

Enzymatic Assay Challenges:

  • Generating properly charged D-Tyr-tRNA^Tyr substrates in sufficient quantities

  • Distinguishing DTD activity from other deacylases that may be present

  • Establishing physiologically relevant reaction conditions

Structural Study Limitations:

  • Obtaining crystal structures of DTD-tRNA complexes has proven difficult

  • The mechanism of discrimination between D and L amino acids remains incompletely characterized

  • Complex structure of DTD with charged-tRNA molecules would provide definitive evidence for the proposed enzyme mechanism, but such structures are challenging to obtain

Functional Analysis Constraints:

  • The intracellular lifestyle of P. amoebophila complicates in vivo studies

  • Limited genetic manipulation tools for P. amoebophila

  • Difficulty in directly measuring the impact of DTD activity on protein translation fidelity within the organism

To overcome these challenges, researchers often employ comparative approaches using better-characterized DTD enzymes from other organisms while developing specialized techniques for working with this obligate intracellular symbiont.

How can P. amoebophila DTD research contribute to developing novel antimicrobials?

Though DTD is highly conserved across species, research on P. amoebophila DTD could inform antimicrobial development through several approaches:

Combination Therapy Strategies:
Studies with Plasmodium DTD have demonstrated that combining D-amino acids with known inhibitors can enhance antimicrobial efficacy. For example, when an inhibitor (N,N-bis[4-amino-2-methyl-6-quinolinyl]urea) was used in combination with D-amino acids, it showed improved inhibitory activity against malaria parasites . Similar strategies could be developed targeting chlamydial pathogens.

Structural Differentiations:
Identifying subtle structural differences between human DTD and its homologs in pathogenic species could enable the development of specific inhibitors. These would target non-human DTD while sparing the human enzyme, reducing potential side effects .

Metabolic Vulnerability Exploitation:
The discovery that P. amoebophila EBs maintain metabolic activity and that D-glucose availability is essential for sustaining this activity suggests that DTD function during the extracellular stage may represent a previously unrecognized vulnerability. Inhibition of DTD combined with D-amino acid exposure during this stage could provide a novel approach to reducing infectivity.

Potential Research Directions:

  • Screening compound libraries for selective inhibitors of chlamydial DTD

  • Testing combinations of D-amino acids with existing antibiotics against Chlamydiaceae

  • Developing assays to evaluate DTD inhibition in host-free systems using purified EBs

  • Investigating whether DTD inhibition affects chlamydial persistence and reactivation

What biotechnological applications could utilize engineered P. amoebophila DTD?

Engineered variants of P. amoebophila DTD hold promise for several biotechnological applications:

Production of D-Amino Acid-Containing Peptides:
Modifications to DTD residues responsible for enantioselectivity could alter its properties to allow incorporation of D-amino acids into growing peptide chains. This could enable in vivo production of D-amino acid-containing peptides and proteins, which have various therapeutic applications .

Enzymatic Resolution of Racemic Amino Acid Mixtures:
Engineered DTD could be used to selectively remove D-amino acids from racemic mixtures, providing a biological method for obtaining pure L-amino acids for pharmaceutical and research applications.

Diagnostic Applications:
The specific activity of DTD against D-amino acid-tRNAs could be harnessed to develop diagnostic assays for detecting the presence of D-amino acids in biological samples.

Analytical Tools:
Modified DTD enzymes could serve as tools for analyzing tRNA charging accuracy in various biological systems or under different stress conditions.

Synthetic Biology Platforms:
Engineered DTD variants could be incorporated into synthetic biology platforms designed to produce proteins with novel properties through controlled incorporation of D-amino acids at specific positions.

The development of these applications would require detailed structural knowledge and protein engineering approaches to modify the enantioselectivity and catalytic properties of the native enzyme.

How does P. amoebophila DTD compare to human DTD homologs?

Comparing P. amoebophila DTD with human homologs reveals important evolutionary and functional relationships:

Human DTD Variants:
Humans possess two types of DTD proteins:

  • DTD1: Part of the DUE-B protein, which has been biochemically and structurally characterized for its deacylase function

  • DTD2: Contains the "PQAT" motif instead of the typical "SQFT" motif found in DTD1

Structural Comparisons:
While specific structural comparisons between P. amoebophila DTD and human homologs are not detailed in the provided search results, DTD proteins typically share a common fold and catalytic mechanism across diverse species. The active site architecture generally includes a nucleophilic threonine residue that attacks the ester bond between D-amino acids and tRNA.

Functional Conservation:
The deacylase function of DTD appears to be highly conserved across all domains of life, suggesting its fundamental importance in maintaining translational fidelity. Both human and bacterial DTDs share the ability to discriminate between D- and L-amino acids and specifically cleave D-amino acid-tRNA complexes.

Evolutionary Implications:
The presence of DTD in all three domains of life, including humans, archaebacteria, and various prokaryotes , indicates that this enzyme emerged early in evolutionary history and has been retained due to its essential role in combating D-amino acid toxicity.

Understanding these similarities and differences could inform the development of DTD-targeted compounds that selectively affect bacterial DTDs while sparing human homologs, potentially leading to new antimicrobial strategies.

What insights does P. amoebophila DTD provide about chlamydial evolution?

P. amoebophila DTD offers valuable insights into chlamydial evolution and adaptation:

Evolutionary Conservation:
The presence of DTD in P. amoebophila, an endosymbiont of free-living amoebae, as well as in pathogenic Chlamydiaceae, highlights the ancient origin and essential nature of this enzyme across the chlamydial lineage. This conservation suggests that DTD emerged before the divergence of environmental and pathogenic chlamydiae.

Adaptation to Intracellular Lifestyle:
As an obligate intracellular bacterium, P. amoebophila has retained DTD despite genome reduction associated with symbiotic lifestyles. This retention underscores the critical importance of maintaining translational fidelity in intracellular environments, where resources may be limited and protein synthesis errors could be particularly costly.

Host Interaction Mechanisms:
P. amoebophila, like other chlamydiae, modifies its inclusion membrane through insertion of unique proteins that interact with and manipulate the host cell . The preservation of DTD alongside these host interaction mechanisms suggests a complementary role in ensuring the correct synthesis of proteins involved in host-symbiont interactions.

Metabolic Adaptations:
The metabolic capabilities of P. amoebophila elementary bodies, including D-glucose metabolism and TCA cycle activity , represent adaptations that differentiate them from the traditionally viewed "metabolically inert" elementary bodies of pathogenic chlamydiae. DTD may play a role in supporting protein synthesis during these metabolically active states.

These evolutionary insights highlight how fundamental cellular processes, such as maintaining translational fidelity through DTD activity, have been preserved while other aspects of chlamydial biology have diverged during adaptation to different host environments.

What are the recommended protocols for purifying native P. amoebophila DTD?

Purification of native DTD from P. amoebophila requires specialized techniques due to the organism's intracellular lifestyle:

Cultivation of P. amoebophila:

  • Grow P. amoebophila-infected Acanthamoeba castellanii in TSY medium (30 g/liter Trypticase soy broth, 10 g/liter yeast extract, pH 7.3) at 20°C

  • Change culture medium every 3-4 days to maintain healthy cultures

  • Harvest unsynchronized cultures when high infection rates are achieved

Elementary Body Isolation:

  • Harvest infected amoebae and wash thoroughly

  • Disrupt amoebae using multiple freeze-thaw cycles (dry ice/ethanol bath followed by rapid thawing in 55°C water bath)

  • Add glass beads and vortex to complete cell disruption

  • Remove cell debris by centrifugation

  • Isolate elementary bodies through density gradient centrifugation

Protein Extraction:

  • Resuspend purified elementary bodies in extraction buffer containing appropriate protease inhibitors

  • Lyse bacterial cells using sonication or detergent treatment

  • Clarify lysate by high-speed centrifugation

DTD Purification Strategy:

  • Initial Fractionation: Ammonium sulfate precipitation or ion exchange chromatography

  • Affinity Chromatography: Using substrate analogs or antibodies against DTD

  • Size Exclusion Chromatography: For final purification and buffer exchange

  • Activity Verification: Perform enzymatic assays to confirm purification of active DTD

This purification protocol may need to be optimized based on the specific characteristics of P. amoebophila DTD and the available laboratory resources. The relatively low abundance of native DTD may necessitate starting with large culture volumes to obtain sufficient protein for analysis.

How can researchers perform site-directed mutagenesis to study P. amoebophila DTD active site?

Site-directed mutagenesis of P. amoebophila DTD enables detailed analysis of structure-function relationships:

Target Selection Strategy:
Based on conservation patterns and known functional regions, researchers should prioritize these targets:

  • The "SQFT" active site motif, particularly the threonine residue crucial for nucleophilic attack

  • The "Gly-Cys-Pro" dipeptide involved in enantioselectivity

  • Phenylalanine and glutamine residues that stabilize the oxyanion hole during catalysis

  • Residues lining the three subsites (transition, active, and exit) of the enzyme

Mutagenesis Protocol:

  • Primer Design:

    • Design complementary primers containing the desired mutation

    • Include 15-20 nucleotides of perfect complementarity on each side of the mutation

    • Ensure primers have appropriate melting temperatures (Tm ~78-82°C)

  • PCR-Based Mutagenesis:

    • Use a high-fidelity DNA polymerase to amplify the entire plasmid

    • Incorporate temperature cycling to denature template DNA, anneal mutagenic primers, and extend

    • Treat with DpnI to digest methylated template DNA, leaving only the mutated product

  • Verification Methods:

    • Sequence the entire coding region to confirm the desired mutation and absence of PCR errors

    • Verify protein expression using SDS-PAGE and western blotting

    • Confirm proper folding using circular dichroism spectroscopy

Functional Analysis of Mutants:

  • Activity Assays:

    • Compare wild-type and mutant enzyme kinetics using standardized deacylation assays

    • Determine changes in Km, kcat, and substrate specificity

  • Structural Analysis:

    • If possible, determine crystal structures of key mutants to understand conformational changes

    • Use molecular dynamics simulations to predict effects of mutations on enzyme dynamics

  • D/L Selectivity Testing:

    • Evaluate how mutations affect discrimination between D- and L-amino acid-tRNA substrates

    • Test with multiple D-amino acids to assess changes in substrate range

A particularly informative mutation would be the replacement of the active site threonine with alanine, which has been shown to significantly reduce catalytic activity in other DTD enzymes . This serves as an important control to validate the conservation of catalytic mechanism.

What are the most promising areas for future P. amoebophila DTD research?

Several promising research directions could significantly advance our understanding of P. amoebophila DTD:

Structural Determinants of Specificity:
Obtaining high-resolution structures of P. amoebophila DTD in complex with various substrate analogs would provide definitive insights into the mechanism of D/L discrimination. Particularly valuable would be a complex structure with a charged tRNA molecule, which has proven challenging to obtain but would validate proposed enzymatic mechanisms .

Evolutionary Adaptations:
Comparative analysis of DTD across the chlamydial lineage could reveal adaptive changes associated with different host ranges and lifestyles. This could help explain how this ancient enzyme has been maintained while accommodating diverse intracellular environments.

Developmental Regulation:
Investigating how DTD expression and activity change during the developmental cycle of P. amoebophila would illuminate its role in different stages of the chlamydial lifecycle, particularly during the transition between elementary bodies and reticulate bodies.

Metabolic Integration:
Exploring how DTD function integrates with the unique metabolic capabilities of P. amoebophila elementary bodies, including D-glucose metabolism and TCA cycle activity , could reveal previously unrecognized connections between metabolism and translational quality control.

Biotechnological Applications:
Developing modified versions of P. amoebophila DTD for the in vivo production of D-amino acid-containing peptides represents an exciting area with therapeutic potential . Engineering DTD to alter its enantioselectivity could enable novel approaches to protein synthesis.

Host-Pathogen Interactions:
Investigating whether DTD plays a role in the survival strategy of P. amoebophila as an intracellular symbiont, particularly in relation to inclusion membrane proteins and host cell manipulation , could reveal unexpected functions beyond translational quality control.

Advances in these areas would not only enhance our understanding of this fascinating enzyme but could also inform broader questions about protein translation fidelity, chlamydial biology, and the development of novel antimicrobial strategies.

How might CRISPR-Cas9 technology be applied to study P. amoebophila DTD function?

CRISPR-Cas9 technology offers powerful approaches for studying P. amoebophila DTD function:

Gene Editing Strategies:

  • Knockout Studies: Creating dtd gene knockouts would allow researchers to directly observe the consequences of DTD absence on P. amoebophila viability, development, and host interaction.

  • Knock-in Approaches: Introducing tagged versions of DTD (e.g., fluorescent or epitope tags) would facilitate visualization of DTD localization and interaction partners within the bacterial cell.

  • Domain Swapping: Replacing specific domains of P. amoebophila DTD with those from other species could help identify determinants of species-specific functions.

  • Point Mutations: Introducing precise mutations in the active site or enantioselectivity motifs would enable detailed structure-function analysis.

Technical Considerations:

  • Delivering CRISPR-Cas9 components into an obligate intracellular bacterium presents significant challenges

  • Transformation protocols for P. amoebophila would need to be optimized

  • Host cell manipulation may be required to facilitate gene editing in the intracellular bacteria

Alternative Approaches:

  • Heterologous Systems: Expressing P. amoebophila DTD and CRISPR components in more tractable bacterial systems

  • Host Cell Manipulation: Editing the amoeba host to affect DTD function indirectly

  • Conditional Expression Systems: Developing inducible systems to control DTD expression

Potential Applications:

  • Creating a library of DTD variants to map structure-function relationships

  • Engineering DTD to accept modified substrates for biotechnological applications

  • Investigating genetic interactions between DTD and other components of the translation machinery

While technical challenges exist, the precision offered by CRISPR-based approaches would provide unprecedented insights into DTD function that would be difficult to achieve through traditional biochemical methods alone.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.